4//SEC Filing
HALE DAVID F 4
Accession 0001209191-22-038041
CIK 0001260990other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:01 PM ET
Size
5.6 KB
Accession
0001209191-22-038041
Insider Transaction Report
Form 4
HALE DAVID F
Director
Transactions
- Award
Stock Options
2022-06-16+37,500→ 37,500 totalExercise: $1.08Exp: 2032-06-16→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001024004
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 6:01 PM ET
- Size
- 5.6 KB